A recent study by Seragon Biosciences presents SRN-901 as a promising anti-aging intervention. In middle-aged mice, the drug extended remaining lifespan by 34.4% and boosted endurance and cognitive function. Dr. David Brown’s findings, backed by machine learning bioinformatics, offer actionable insights for enhancing healthspan. Reviewing these results may guide future therapeutic strategies.